Craniometrix
Craniometrix is a YC Winter 2022 (W22) company. Based in New York, NY, USA. Team of 36.
About Craniometrix
Summary
Craniometrix builds an AI-powered care navigation service for dementia patients and their families. It delivers non-clinical coaching and support that keeps patients at home longer, reducing avoidable hospitalizations that would otherwise fall on families and providers to manage. Medicare reimburses the service, replacing ad-hoc caregiver guidance with a structured, scalable support model.
Business model
Reimbursed by Medicare per enrolled dementia patient
Go-to-market
Dementia patients and family caregivers are the end beneficiaries, reached through a care navigation service that sits alongside existing providers and is billed directly to Medicare.
From the Y Combinator listing
Using AI to help dementia patients age at home
Craniometrix has raised over $21 million to help make dementia suck less. Dementia is tough – but it can be easier. Turns out, if you give families the right non-clinical coaching and support, you can avoid 30% of hospitalizations for these patients. And Medicare has recently started paying for that coaching. We launched our care navigation service for dementia patients in July of 2025, hit $4M of ARR, and just raised a $15M Series A. We leverage AI to provide best-in-class care, alleviating the burden on providers. Come help us build!
Facts
- Healthcare / Healthcare
- New York, NY, USA
- 36
- Active
- Early
Founders (1)
- Nikhil Patel
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works